Cléry
Also known as CLERY, Groupe Cléry, Family Office Cléry
Paris investment company of Photosol co-founders David Guinard and Robin Ucelli, funded by the 2022 Photosol sale; impact stakes in startups, plus real estate and hospitality.
USEFUL FOR Co-investors
Paris investment company (SAS, SIREN 920 509 049) of Photosol co-founders David Guinard and Robin Ucelli. Not related to other French companies named Cléry.
Family & background
- FAMILY
- Guinard and Ucelli families (co-founders David Guinard and Robin Ucelli)
- WEALTH ORIGIN
- Photosol (solar power producer), majority sold in 2022
- HEADQUARTERS
- Paris, France
- FOUNDED
- 2022
Investment approach
- SECTORS
- Climate & EnergyHealthTechBiotech & Life SciencesMobility & LogisticsSpaceReal Estate & PropTechFood & Agriculture
- ROUTES
- Direct investments
- STRATEGIES
- ImpactDirect investmentsReal estate
Overview
Cléry was created by David Guinard and Robin Ucelli, who founded solar producer Photosol in 2008, with the proceeds of the sale of a majority of Photosol's capital in 2022. Its site describes it as the family office structured for the two founders and lists investment areas in energy transition and climate adaptation, preventive health and medical innovation, real estate and hospitality, low-carbon mobility and space. The portfolio page lists 15 companies, including AdEchoTech, inHeart, Primaa, Notpla and Zeway; in October 2024 Cléry said the Hepta Medical deal was its 17th investment in 18 months.
Investment thesis
Invests with the stated aim of positive social or environmental change alongside long-term financial return, providing capital “in all its forms”, expertise and network to committed entrepreneurs in energy transition, preventive health and medical innovation, real estate and hospitality, low-carbon mobility and space.
Holdings & investments (15)
- inHeartNOTABLEHealthTech
- NotplaNOTABLEClimate & Energy
- Hepta MedicalHealthTech · since 2024
- PrimaaHealthTech · since 2024
- AdEchoTechHealthTech
- AlatyrSpace
- Carbo CultureClimate & Energy
- Clarity Health TechnologiesHealthTech
- Cold PadIndustrial & Manufacturing
- NeofarmFood & Agriculture
- OnafisFood & Agriculture
- One.FiveClimate & Energy
- SeparativeIndustrial & Manufacturing
- Tafalgie TherapeuticsBiotech & Life Sciences
- ZewayMobility & Logistics
People
- Morgan RiedwegResponsable des investissements Immobiliers - Hôtellerie · source
- Vincent DampierreResponsable des Relations Investisseurs · source
- Robin UcelliPrésident (co-founder) · source
- David GuinardDirecteur Général (co-founder) · source
- Nicolas CaillensDirecteur Général Délégué et Secrétaire Général · source
- Christophe KicaDirecteur des participations · source
- Pierre-Henri ThiretDirecteur des participations · source
- Camille CiottaAnalyste · source
- Cyril BillioudDirecteur des affaires juridiques · source
Classification
Family Holding. A family's holding company that owns stakes in several separate businesses or invests beyond its own group, without calling itself a family office. How family capital is classified →
FAQ
Cléry is a family holding based in Paris, France, founded in 2022.
Cléry invests on behalf of the Guinard and Ucelli families (co-founders David Guinard and Robin Ucelli) family (Photosol (solar power producer), majority sold in 2022).
Cléry invests directly in companies. Its stated asset mix includes impact, direct investments and real estate.
Cléry invests in Climate & Energy, HealthTech, Biotech & Life Sciences, Mobility & Logistics, Space, Real Estate & PropTech and Food & Agriculture.
Key people at Cléry include Robin Ucelli (Président (co-founder)), David Guinard (Directeur Général (co-founder)), Nicolas Caillens (Directeur Général Délégué et Secrétaire Général) and Christophe Kica (Directeur des participations).
Cléry's holdings and investments include inHeart, Notpla, AdEchoTech, Alatyr, Carbo Culture, Clarity Health Technologies, Cold Pad and Hepta Medical, among others.
The most recent publicly reported investment by Cléry is Primaa (€5M round alongside CENITZ and Leia Capital), announced in Dec 2024.